2024-03-05 07:41:17 ET
Summary
- Bayer reported full-year results and had to report declines for the top and bottom line.
- Management cut the dividend to 11 cents in order to get the huge debt levels under control.
- The stock might still be undervalued but with all the risks surrounding the business, it might be best to stay to the sidelines.
One of the companies reporting full-year results today, was the German life science and pharmaceutical company Bayer AG ( BAYZF ). And so far, investors are neither optimistic nor pessimistic about the results – the stock is fluctuating around the previous day’s closing price....
Read the full article on Seeking Alpha
For further details see:
Bayer Fiscal 2023 Results: Mr. Anderson, Deliver Us From Bad News (Rating Downgrade)